Abdenor Badaoui

Dr. Abdenor Badaoui

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in Endoscopy
Verified
Journal Article
Closed access
PDF file
ABAbdenor Badaoui
Abdenor Badaoui
SCSara Teles de Campos
Sara Teles de Campos
PFPietro Fusaroli
Pietro Fusaroli
RGRodica Gincul
Rodica Gincul
MKMichel Kahaleh
Michel Kahaleh
TTTony Tham
Tony Tham
Main Recommendations: The European Society of Gastrointestinal Endoscopy (ESGE) has recognized the need to formalize and enhance training in diagnostic endoscopic ultrasound (EUS). This manuscript represents the outcome of a formal Delphi process resulting in an official Position Statement of the ESGE and provides a framework to develop and maintain skills in diagnostic EUS. This curriculum is set out in terms of the prerequisites prior to training; the recommended steps of training to a defined syllabus; the quality of training; and how competence should be defined and evidenced before independent practice. 1 Trainees should have achieved competence in upper gastrointestinal endoscopy before training in diagnostic EUS. 2 The development of diagnostic EUS skills by methods that do not involve patients is advisable, but not mandatory, prior to commencing formal training in diagnostic EUS. 3 A trainee’s principal trainer should be performing adequate volumes of diagnostic EUSs to demonstrate maintenance of their own competence. 4 Training centers for diagnostic EUS should offer expertise, as well as a high volume of procedures per year, to ensure an optimal level of quality for training. Under these conditions, training centers should be able to provide trainees with a sufficient wealth of experience in diagnostic EUS for at least 12 months. 5 Trainees should engage in formal training and supplement this with a range of learning resources for diagnostic EUS, including EUS-guided fine-needle aspiration and biopsy (FNA/FNB). 6 EUS training should follow a structured syllabus to guide the learning program. 7 A minimum procedure volume should be offered to trainees during diagnostic EUS training to ensure that they have the opportunity to achieve competence in the technique. To evaluate competence in diagnostic EUS, trainees should have completed a minimum of 250 supervised EUS procedures: 80 for luminal tumors, 20 for subepithelial lesions, and 150 for pancreaticobiliary lesions. At least 75 EUS-FNA/FNBs should be performed, including mostly pancreaticobiliary lesions. 8 Competence assessment in diagnostic EUS should take into consideration not only technical skills, but also cognitive and integrative skills. A reliable valid assessment tool should be used regularly during diagnostic EUS training to track the acquisition of competence and to support trainee feedback. 9 A period of supervised practice should follow the start of independent activity. Supervision can be delivered either on site if other colleagues are already practicing EUS or by maintaining contacts with the training center and/or other EUS experts. 10 Key performance measures including the annual number of procedures, frequency of obtaining a diagnostic sample during EUS-FNA/FNB, and adverse events should be recorded within an electronic documentation system and evaluated.

25 September 2023 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
JMJulieta Montanelli
Julieta Montanelli
LSLeonardo Sosa-Valencia
Leonardo Sosa-Valencia
ABAbdenor Badaoui
Abdenor Badaoui
GAGerlinde Averous
Gerlinde Averous
LSLee Swanstrom
Lee Swanstrom
BSBarbara Seeliger
Barbara Seeliger
Background and study aims Pancreatic surgery remains complex, particularly for borderline resectable and locally advanced tumors. Vascular invasion compromises resectability, and vascular resection entails increased morbidity and mortality. Following a feasibility and safety demonstration of augmented endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) using hydroxyethyl starch (HES) in porcine pancreatic parenchyma, the present study assesses whether this approach (EUS-sugar-RFA) in the pancreatic perivascular space is safe and creates a controllable margin of necrosis to enable a vessel-sparing resection. Methods EUS-sugar-RFA in the pancreatic parenchyma adjacent to the splenic artery and vein was performed in a live animal model. Following different survival periods (0–4 days) in the interventional group (n = 3), open pancreatectomy was carried out. The control group (n = 4) included open pancreatectomies in two pigs with non-treated pancreases and in two with pancreatic RFA alone on the same day. Results All procedures were completed successfully, without intraoperative or postoperative complications. Survival periods were uncomplicated. Histopathological examination showed local necrosis and inflammatory reaction at the ablation sites. Vascular wall integrity was preserved in all specimens. The untreated pancreatic zones in the interventional group were no different from the normal pancreases in the control group. Conclusions Preoperative perivascular augmented RFA using HES was safe, and in the pancreatic animal model, the best timeframe was within 24 hours before pancreatic surgery. This technique might improve resectability in selected borderline and locally advanced pancreatic cancers.

9 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ABAbdenor Badaoui
Abdenor Badaoui
MWMarion de Wergifosse
Marion de Wergifosse
BRBenoit Rondelet
Benoit Rondelet
PDPierre H. Deprez
Pierre H. Deprez
CSClaudia Stanciu-Pop
Claudia Stanciu-Pop
LPLionel Pirard
Lionel Pirard
Background: Combined endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound-guided tissue acquisition (EUS-TA) are accurate procedures for the diagnosis and staging of mediastinal lymph nodes (MLNs) in lung cancer. However, the respective contribution of separate and combined procedures in diagnosis and staging has not been fully studied. The aim of this study was to assess their respective performances. Methods: Patients with suspected malignant MLNs in lung cancer or recurrence identified by PET-CT who underwent combined EBUS-TBNA and EUS-TA were retrospectively reviewed. Results: A total of 141 patients underwent both procedures. Correct diagnosis was obtained in 82% with EBUS-TBNA, 91% with EUS-TA, and 94% with the combined procedure. The overall sensitivity, specificity, and positive and negative predictive values (PPV and NPV) of EBUS-TBNA, EUS-TA, and the combined procedure for diagnosing malignancy were [75%, 100%, 100%, 58%], [87%, 100%, 100%, 75%], and [93%, 100%, 100%, 80%], respectively, with a significantly better sensitivity of the combined procedure (p < 0.0001). Staging (82/141 patients) was correctly assessed in 74% with EBUS-TBNA, 68% with EUS-TA, and 85% with the combined procedure. The overall sensitivity, specificity, PPV, and NPV of EBUS-TBNA, EUS-TA, and the combined procedure for lung cancer staging were [62%, 100%, 100%, 55%], [54%, 100%, 100%, 50%], and [79%, 100%, 100%, 68%], respectively, significantly better in terms of sensitivity for the combined procedure (p < 0.001). Conclusion: The combined EBUS-EUS approach in lung cancer patients showed better accuracy and sensitivity in diagnosis and staging when compared with EBUS-TBNA and EUS-TA alone.

9 January 2024 in Endoscopy
Verified
Journal Article
Open access
PDF file
PMPierre Mayer
Pierre Mayer
LHLucile Héroin
Lucile Héroin
FHFrançois Habersetzer
François Habersetzer
PCPierre-Yves Christmann
Pierre-Yves Christmann
JHJérôme Huppertz
Jérôme Huppertz
ABAbdenor Badaoui
Abdenor Badaoui
Curative management of esophageal adenocarcinoma is based on esophagectomy. One of the main complications is anastomotic fistula (30%) [1], which is responsible for significant postoperative morbidity and mortality, as well as reduced survival [2]. In recent years, endoscopic treatment of anastomotic fistulas has become a valuable option, enabling closure of the fistula and a reduction in the mortality rate [3] [4]. We report the case of a 55-year-old patient who underwent a Lewis Santy esophagectomy for esophageal adenocarcinoma. The patient developed an anastomotic fistula with a pleural abscess requiring antibiotics, thoracic drainage, and placement of a partially covered self-expandable metal stent (PCSEMS) to cover the fistula. However, the thoracic drainage remained highly productive and an endoscopy revealed migration of the stent’s distal flange, with embedment into the fistula ([Fig. 1] and [Fig. 2]). After several unsuccessful attempts at endoscopic removal, the patient was transferred to our center. He presented to us with a chronic pleural infection and total dependence on parenteral nutrition. An endoscopic procedure to re-establish digestive continuity was planned. The lower pole of the fibrin-wrapped stent and a productive fistulous orifice were identified ([Fig. 3]). We managed to pass the scope in parallel to the stent to gain access to the gastroplasty. After a guidewire had been positioned in the gastroplasty, a fully covered metal stent (FCSEMS) was placed in parallel and successfully re-established digestive continuity and excluded the fistula ([Video 1]). The FCSEMS was removed after 3 months, but the PCSEMS remained irremovable. After discussion with the surgical team, it was decided to try the stent-in-stent technique [5], and a new FCSEMS was inserted inside the PCSEMS ([Fig. 4]). A further endoscopy was performed 2 weeks later, at which the FCSEMS was removed without difficulty, but the PCSEMS remained embedded. Given the impossibility of endoscopic PCSEMS removal, it was decided that surgical management would be required and the patient underwent surgical removal of the PCSEMS and coloplasty. Endoscopy_UCTN_Code_TTT_1AO_2AI Article published online: 07 August 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

15 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Elettra MerolaElettra Merola
Elettra Merola
LVLeonardo Sosa Valencia
Leonardo Sosa Valencia
NPNico Pagano
Nico Pagano
Maria Pina DoreMaria Pina Dore
Maria Pina Dore
JMJulieta Montanelli
Julieta Montanelli
ABAbdenor Badaoui
Abdenor Badaoui
The use of artificial intelligence (AI) in endoscopic ultrasonography (EUS) is receiving increasing attention, particularly in the field of pancreatic diseases, where early and accurate diagnosis remains a major clinical challenge. This narrative review focuses on current and emerging applications of AI in pancreatic EUS, covering both image-based diagnostic support and the analysis of samples obtained through EUS-guided tissue acquisition. The first part of the review discusses how AI is being applied to improve EUS image interpretation, ranging from lesion detection to characterization and differentiation between benign and malignant pancreatic findings. The review also discusses early evidence and future perspectives for real-time procedural support, where diagnostic performance remains highly operator-dependent. The second part explores a less frequently discussed but equally relevant area: the use of AI in the analysis of cytological specimens obtained through EUS-guided fine-needle aspiration or fine-needle biopsy. Although cytopathology may appear to lie outside the traditional clinical scope of EUS, it represents an essential step in the diagnostic workflow of pancreatic diseases. Recent developments in AI-assisted digital cytology and pathology have shown promising potential to support and standardize cytological interpretation, with possible benefits in terms of diagnostic consistency, reproducibility, and turnaround time. By bridging imaging and pathology, AI may enhance the entire pancreatic EUS workflow, contributing to more efficient, accurate, and personalized diagnostic pathways in pancreatic disease management.

30 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Elettra MerolaElettra Merola
Elettra Merola
LSLeonardo Sosa-Valencia
Leonardo Sosa-Valencia
AMAndrea Michielan
Andrea Michielan
NPNico Pagano
Nico Pagano
Maria Pina DoreMaria Pina Dore
Maria Pina Dore
ABAbdenor Badaoui
Abdenor Badaoui
Artificial intelligence is increasingly being applied to endoscopic ultrasonography for gastrointestinal subepithelial lesions, but the maturity of the evidence differs substantially across clinical tasks. This narrative review critically appraises contemporary studies of lesion detection and localization, wall-layer identification, diagnostic classification, pathological risk classification of gastrointestinal stromal tumors, human–artificial intelligence interaction, and potential management support. Thirty-one original studies published from 2021 through 2026 were included in the contemporary evidence map. Binary differentiation of gastrointestinal stromal tumors from leiomyomas or other selected comparators has the largest evidence base and includes multicenter, external, prospective, and real-time evaluations. Evidence for multiclass diagnosis, layer-of-origin assessment, small lesions, and pathological risk classification is less mature and is strongly influenced by case spectrum, reference standard, equipment, image selection, and validation design. No study has demonstrated that artificial intelligence improves tissue-acquisition strategy, surveillance, treatment selection, or patient outcomes in subepithelial lesions. Progress toward clinically useful decision support will require patient-level data separation, device- and center-held-out validation, analysis of complete examinations rather than curated images, explicit uncertainty handling, prospective human–artificial intelligence studies, and trials with endoscopy-specific management and safety outcomes.